Table 4

Differential expression of potential immunotherapy target genes in STS samples


Percent of Samples Expressing Gene


Gene Symbol
 Gene Name
 AF
 Liposarcoma
 LMS
 Myxoid Liposarcoma
 Synovial
 MFH-B
 MFH-A
CTAG2
 cancer/testis antigen 2
 0
 60
 0
 71
 75
 0
 0
CTAGE5
 CTAGE family, member 5
 75
 60
 44
 29
 25
 71
 67
MAGEA9
 melanoma antigen family A, 9
 0
 40
 111
 71
 75
 14
 0
MAGED1
 melanoma antigen family D, 1
 100
 100
 100
 100
 100
 100
 100
MAGED2
 melanoma antigen family D, 2
 100
 80
 89
 100
 50
 86
 78
MAGED4
 melanoma antigen family D, 4
 92
 80
 78
 57
 100
 57
 44
MAGEF1
 melanoma antigen family F, 1
 92
 100
 100
 100
 75
 86
 78
MAGEH1
 melanoma antigen family H, 1
 92
 100
 100
 71
 100
 86
 100
PRAME
 preferentially expressed antigen in melanoma
 0
 100
 33
 86
 100
 0
 11

Skubitz et al. Journal of Translational Medicine 2008 6:23   doi:10.1186/1479-5876-6-23